CareF A Injection (L-Carnitine)

Adult administration

1. Primary and secondary carnitine deficiency Myocardial metabolic disorder due to ischemic heart disease: angina pectoris, acute myocardial infarction Adults: Administer 2~3 grams of L-carnitine per day in 2~3 divided doses by intramuscular or intravenous injection. Adjust the dose appropriately according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10~20 milligrams/kilogram intravenously over 2~3 minutes at the end of each hemodialysis session. However, the dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

This medication is provided in injection form, and extreme caution should be exercised when opening the container, as glass fragments may contaminate the solution. Special care is needed when used by children or elderly individuals. It should not be used in patients with allergic reactions to this medication. Temporary nausea or vomiting may occur with the use of this medication. Rarely, changes in body odor or gastritis have been reported, and patients with a history of seizures may experience more frequent or severe seizures. In studies conducted on patients undergoing chronic hemodialysis, various side effects were reported, including abdominal pain, allergic reactions, headaches, infections, injection site pain, cardiac issues, dyspepsia, blood-related abnormalities, weight changes, muscle pain, neurological symptoms, respiratory problems, and skin rashes. Patients taking this medication orally may experience rashes, hives, and facial swelling, while patients with impaired kidney function have reported symptoms of muscle weakness. Women who are pregnant or may become pregnant should use this medication only when the benefits outweigh the risks, as the safety of this medication is not well established. Furthermore, there is no information on whether this medication is excreted in breast milk, but since many medications are transferred to breast milk, nursing mothers should use this medication with caution.

• temporary dizziness
• vomiting
• body odor
• gastritis
• seizures
• abdominal pain
• accidental injury
• allergic reaction
• asthma
• back pain

This medication is light-sensitive and should be stored in an opaque container. It is also recommended to keep it at room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance

A clear solution ranging from colorless to pale yellow contained in a transparent brown glass ampule.

Package unit

For domestic use - 5 milliliters/ampule [5 mL x 10 ampules], For domestic use - 5 milliliters/ampule [5 mL x 25 ampules], For export - 5 milliliters/ampule [5 mL x 10 ampules], For export - 5 milliliters/ampule [5 mL x 25 ampules], For export - 5 milliliters/ampule [5 mL x 50 ampules]